Multicenter Austrian Hemodilution Stroke Trial "MAHST"

Completed

Phase N/A Results

Summary of Purpose

To test the safety and potential improvement in neurological recovery of acute ischemic stroke patients treated with mild hypervolemic hemodilution (HHD) with low substituted 10% hydroxyethyl starch (HES) compared to pure rehydration with crystalloid fluid .

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 31 October 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Randomized, double-blind, placebo-controlled study of 200 patients at 15 Austrian hospitals.

Contacts

  • Franz T. Aichner, MD, Department of Neurology and Magnetic Resonance, University Hospital, Anichstra├če 35, 6020 Innsbruck, Austria.

    mriinstitute@uibk.ac.at